BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20153664)

  • 1. Effect of induction chemotherapy on lung function and exercise capacity in patients affected by malignant pleural mesothelioma.
    Marulli G; Rea F; Nicotra S; Favaretto AG; Perissinotto E; Chizzolini M; Vianello A; Braccioni F
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1464-9. PubMed ID: 20153664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
    Yamanaka T; Tanaka F; Hasegawa S; Okada M; Soejima T; Kamikonya N; Fukuoka K; Nakano T
    Jpn J Clin Oncol; 2009 Mar; 39(3):186-8. PubMed ID: 19131427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of lung motion in patients with malignant pleural mesothelioma using two-dimensional and three-dimensional dynamic magnetic resonance imaging: comparison with spirometry.
    Plathow C; Klopp M; Schoebinger M; Thieke C; Fink C; Puderbach M; Ley S; Weber MA; Sandner A; Claussen CD; Herth F; Tuengerthal S; Meinzer HP; Kauczor HU
    Invest Radiol; 2006 May; 41(5):443-8. PubMed ID: 16625107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations.
    Stewart DJ; Martin-Ucar AE; Edwards JG; West K; Waller DA
    Eur J Cardiothorac Surg; 2005 Mar; 27(3):373-8. PubMed ID: 15740941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients.
    Nakagawa K; Yamazaki K; Kunitoh H; Hida T; Gemba K; Shinkai T; Ichinose Y; Adachi S; Nambu Y; Saijo N; Fukuoka M
    Jpn J Clin Oncol; 2008 May; 38(5):339-46. PubMed ID: 18434338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimodality therapy for malignant pleural mesothelioma.
    Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
    Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.
    Pasello G; Ceresoli GL; Favaretto A
    Cancer Treat Rev; 2013 Feb; 39(1):10-7. PubMed ID: 22459200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of muscle flap in preventing bronchus stump insufficiency after pneumonectomy for malignant pleural mesothelioma in high-risk patients.
    Beshay M; Carboni G; Hoksch B; Reymond MA; Schmid RA
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):621-4; discussion 624-5. PubMed ID: 18381361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma.
    Friedberg JS
    Semin Thorac Cardiovasc Surg; 2009; 21(2):177-87. PubMed ID: 19822291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
    In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis.
    Sidi R; Pasello G; Opitz I; Soltermann A; Tutic M; Rehrauer H; Weder W; Stahel RA; Felley-Bosco E
    Eur J Cancer; 2011 Jan; 47(2):326-32. PubMed ID: 21036600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment option.
    Razak AR; Chatten KJ; Hughes AN
    Lung Cancer; 2008 May; 60(2):294-7. PubMed ID: 17919769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
    Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in pulmonary function tests predict radiological response to chemotherapy in malignant pleural mesothelioma.
    Marulli G; Di Chiara F; Braccioni F; Perissinotto E; Pasello G; Favaretto AG; Breda C; Rea F
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):104-10. PubMed ID: 23349323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
    van Meerbeeck JP; Gaafar R; Manegold C; Van Klaveren RJ; Van Marck EA; Vincent M; Legrand C; Bottomley A; Debruyne C; Giaccone G; ;
    J Clin Oncol; 2005 Oct; 23(28):6881-9. PubMed ID: 16192580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant pleural mesothelioma: current treatments and emerging drugs.
    Belli C; Fennell D; Giovannini M; Gaudino G; Mutti L
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):423-37. PubMed ID: 19552609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current trends in the management of malignant pleural mesothelioma.
    Tsiouris A; Gourgoulianis KI; Walesby RK
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):831-3. PubMed ID: 16761925
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].
    Sienel W; Kirschbaum A; Passlick B
    Zentralbl Chir; 2008 Jun; 133(3):231-7. PubMed ID: 18563687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.
    Cerfolio RJ; Talati A; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):930-5; discussion 935-6. PubMed ID: 19699923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.